Overall Status

Completed (22)

Terminated (6)

Phase

phase 1 (15)

phase 2 (10)

phase 1/phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

National Cancer Institute (NCI) (16)

Bristol-Myers Squibb (4)

Cancer Research UK (2)

Memorial Sloan Kettering Cancer Center (2)

Barbara Ann Karmanos Cancer Institute (1)

Jonsson Comprehensive Cancer Center (1)

Mayo Clinic (1)

National Institutes of Health Clinical Center (CC) (1)

Collaborator

National Cancer Institute (NCI) (7)

Study Documents

Intervention Type

drug (28)

other (8)

biological (1)

procedure (1)

Funder Type

NIH (17)

Other (7)

Industry (4)

Study Type

Interventional (28)

tanespimycin

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (tanespimycin)

Completed

Chronic Myeloproliferative Disorders
+4 more

tanespimycin

Bethesda, Maryland
+1 more

Mar 14, 2012

Lymphoma, Solid Tumor Trial in Rochester (tanespimycin)

Completed

Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

tanespimycin

Rochester, Minnesota

Mayo Clinic

Aug 2, 2011

Multiple Myeloma Trial in Canada, United States (Tanespimycin, Bortezomib)

Completed

Multiple Myeloma

Tanespimycin
Bortezomib

Bakersfield, California
+18 more

Jun 21, 2011